Haleon PLC Total Assets
Haleon PLC total assets. Based on the latest financial reports, Haleon PLC (HLN) holds total assets worth GBX31.83 Billion GBX (≈ $3.87 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Haleon PLC (HLN) total market value for the company's overall valuation and market capitalisation.
Total Assets of Haleon PLC (2019–2024)
Total assets of Haleon PLC from 2019 to 2024. This chart illustrates how Haleon PLC's total assets have evolved over time, based on quarterly financial data. See HLN stock price and chart for real-time trading data and today's change.
Haleon PLC - Asset Composition Analysis
Haleon PLC Total Assets Breakdown (December 2024)
Haleon PLC total assets breakdown as of December 2024. Haleon PLC's total assets of GBX31.83 Billion consist of 16.7% current assets and 83.3% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 6.4% |
| Accounts Receivable | GBX1.90 Billion | 5.6% |
| Inventory | GBX1.19 Billion | 3.5% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX18.01 Billion | 52.5% |
| Goodwill | GBX8.20 Billion | 23.9% |
Asset Composition Trend (2019–2024)
This chart illustrates how Haleon PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Haleon PLC to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Haleon PLC's current assets represent 16.7% of total assets in 2024, an increase from 16.3% in 2019.
- Cash Position: Cash and equivalents constituted 6.4% of total assets in 2024, up from 1.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 75.0% of total assets, a decrease from 77.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 52.5% of total assets.
Haleon PLC Competitors by Total Assets
Key competitors of Haleon PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
Haleon PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.87 | 0.84 | 1.24 |
| Quick Ratio | 0.63 | 0.58 | 1.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX-620.00 Million | GBX-914.00 Million | GBX1.01 Billion |
Haleon PLC - Advanced Valuation Insights
This section examines the relationship between Haleon PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.11 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 0.8% |
| Total Assets | GBX34.31 Billion |
| Market Capitalization | $346.10 Million USD |
Valuation Analysis
Below Book Valuation: The market values Haleon PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Haleon PLC's assets grew by 0.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Haleon PLC (2019–2024)
The table below shows the annual total assets of Haleon PLC from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX34.31 Billion ≈ $4.18 Million |
+0.76% |
| 2023-12-31 | GBX34.05 Billion ≈ $4.14 Million |
-2.18% |
| 2022-12-31 | GBX34.81 Billion ≈ $4.24 Million |
+1.06% |
| 2021-12-31 | GBX34.45 Billion ≈ $4.19 Million |
+0.94% |
| 2020-12-31 | GBX34.13 Billion ≈ $4.15 Million |
-4.43% |
| 2019-12-31 | GBX35.71 Billion ≈ $4.34 Million |
-- |
About Haleon PLC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more